Thursday, March 26, 2015 7:52:22 PM
NEW YORK, March 25, 2015 /PRNewswire/
S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on Abattis Bioceuticals Corp.
Abattis Bioceuticals (OTCQX: ATTBF; CSE: ATT): is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The company seeks to capitalize on the current trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. Abattis also has an extensive pipeline of products and intellectual property for the botanical drug market.
http://otc.club/marijuana-stocks/sp-capital-iq-initiates-coverage-on-abattis-bioceuticals-corp-in-sp-capital-iq-factual-stock-reports/
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM